2021
DOI: 10.3390/ijms221810023
|View full text |Cite
|
Sign up to set email alerts
|

Lactobacillus plantarum HY7715 Ameliorates Sarcopenia by Improving Skeletal Muscle Mass and Function in Aged Balb/c Mice

Abstract: Sarcopenia is a loss of muscle mass and function in elderly people and can lead to physical frailty and fall-related injuries. Sarcopenia is an inevitable event of the aging process that substantially impacts a person’s quality of life. Recent studies to improve muscle function through the intake of various functional food materials are attracting attention. However, it is not yet known whether probiotics can improve muscle mass and muscle strength and affect physical performance. Lactobacillus plantarum HY771… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
28
0

Year Published

2021
2021
2025
2025

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 37 publications
(28 citation statements)
references
References 62 publications
0
28
0
Order By: Relevance
“…Butyrate is a short-chain fatty acid with anti-inflammatory and anticancer properties, and recent studies have reported an association with sarcopenia [34]. Interestingly, based on the recently published results for ameliorates sarcopenia of HY7715 [35], considering the changes in the butyrate concentration and butyrate-producing bacteria in the HY7715-treated group, the HY7715 intake has the potential to improve sarcopenia, but studies on the interaction between the microbiome and its metabolites should be conducted. Future studies using the simulated gut system require metabolomics-related research to understand comprehensive changes in complex metabolites produced by diverse microbial communities and influenced by their interaction.…”
Section: Discussionmentioning
confidence: 99%
“…Butyrate is a short-chain fatty acid with anti-inflammatory and anticancer properties, and recent studies have reported an association with sarcopenia [34]. Interestingly, based on the recently published results for ameliorates sarcopenia of HY7715 [35], considering the changes in the butyrate concentration and butyrate-producing bacteria in the HY7715-treated group, the HY7715 intake has the potential to improve sarcopenia, but studies on the interaction between the microbiome and its metabolites should be conducted. Future studies using the simulated gut system require metabolomics-related research to understand comprehensive changes in complex metabolites produced by diverse microbial communities and influenced by their interaction.…”
Section: Discussionmentioning
confidence: 99%
“…Anti-inflammatory, butyrate producer with probiotic effect [120][121][122], its beneficial effects are demonstrated also in CNS (altered behaviors, depression, anxiety, stress, cognitive impairment, andAD models) [123][124][125][126][127][128]; reduced sarcopenic process and physical frailty in mice [129].…”
Section: Lactobacillusmentioning
confidence: 99%
“…The benefits of probiotics have also been investigated using rodent models of aging [SAMP-8 ( 30 32 ) and D-galactose ( 33 )] and animal models of cachexia ( 34 ). However, researchers have rarely used healthy older rodents ( 35 ) and have never used “frail” rodents, such as older, food-restricted rats.…”
Section: Introductionmentioning
confidence: 99%